Tag: Zinbryta
NICE recommends Zinbryta (daclizumab) for relapsing-remitting multiple sclerosis
The National Institute for Health and Care Excellence (NICE) has recommended ZINBRYTA (daclizumab) from Biogen for the treatment of adult patients living with relapsing-remitting...